TABLE 1.
Variable | Ventilated (n = 20) | CPAP (n = 34) | Not ventilated (n = 50) | P value ventilated v CPAP | P value ventilated v not ventilated | P value CPAP v not ventilated |
---|---|---|---|---|---|---|
Age | 59 (44–73) | 66 (46–72) | 49 (42–65) | NS | NS | NS |
Female | 11 (55%) | 17 (50%) | 22 (44%) | NS | NS | NS |
Days in hospital | 13 (9–20) | 6 (4–13) | 12 (1–19) | NS | NS | NS |
PT (s) | 11.4 (10.9) | 11.3 (10.8–12.6) | 10.9 (10.5–11.5) | NS | .03 | .005 |
APTT (s) | 27.4 (25.2–32.9) | 28.6 (25.0–32.1) | 25.4 (24.1–29.5) | NS | NS | NS |
Fibrinogen (g/L) | 5.33 (3.74–6.32) | 6.22 (4.77–7.66) | 5.40 (4.45–6.68) | NS | NS | NS |
D‐dimer (mg/L) | 6.55 (2.08–42.27) | 1.56 (0.80–5.680 | 0.71 (0.42–0.94) | .008 | <.0001 | .0003 |
FDP (mg/mL) | 13.9 (6.7–81.5) | 4.9 (2.9–17.8) | 2.7 (2.5–4.1) | .02 | <.0001 | .002 |
Antithrombin (IU/mL) | 79.0 (72.8–100.7) | 95.4 (84.6–107.4) | 96.6 (83.0–104.9) | NS | NS | NS |
WBC | 9.2 (7.3–14.8) | 8.4 (5.4–11.5) | 6.8 (4.9–8.8) | NS | .003 | .008 |
Neutrophils x109/L | 8.28 (5.67–13.17) | 6.91 (4.31–10.74) | 5.49 (3.73–7.09) | NS | .01 | .03 |
Lymphocytes x109/L | 0.77 (0.50–1.14) | 0.75 (0.58–0.98) | 0.91 (0.64–1.19) | NS | NS | NS |
Platelets x109/L | 218 (143–282) | 239 (167–304) | 236 (190–328) | NS | NS | NS |
TAT (ng/mL) | 18.1 (13.2–24.9) | 13.2 (9.0–22.1) | 9.4 (7.9–16.6) | <.006 | <.0001 | <.0001 |
sTM (TU/mL) | 25.7 (8.6–79.4) | 9.1 (5.9–16.5) | 4.5 (2.9–7.1) | .05 | .0005 | NS |
tPAI‐C (ng/mL) | 24.1 (13.5–40.7) | 19.4 (15.5–34.1) | 16.8 (12.3–20.5) | NS | NS | NS |
PIC (μg/mL) | 2.475 (1.320–15.766) | 2.220 (1.716–3.383) | 1.683 (1.17–2.449) | NS | .04 | .04 |